Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LFCR

Lifecore Biomedical (LFCR)

Lifecore Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LFCR
DateTimeSourceHeadlineSymbolCompany
12/19/20244:05PMGlobeNewswire Inc.Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025NASDAQ:LFCRLifecore Biomedical Inc
12/19/20247:00AMGlobeNewswire Inc.Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentNASDAQ:LFCRLifecore Biomedical Inc
12/10/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
12/10/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
11/26/20245:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
11/26/20244:05PMGlobeNewswire Inc.Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMONASDAQ:LFCRLifecore Biomedical Inc
11/21/20244:17PMGlobeNewswire Inc.Lifecore Biomedical Hosts Virtual Investor DayNASDAQ:LFCRLifecore Biomedical Inc
11/21/20247:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
11/20/202410:14AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
11/12/20244:05PMGlobeNewswire Inc.Lifecore Biomedical to Present at Stephens Annual Investment ConferenceNASDAQ:LFCRLifecore Biomedical Inc
11/12/20242:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
11/08/20244:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
11/07/20247:00AMGlobeNewswire Inc.Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024NASDAQ:LFCRLifecore Biomedical Inc
11/04/20247:00AMGlobeNewswire Inc.Lifecore Biomedical Appoints Thomas Guldager as Vice President, OperationsNASDAQ:LFCRLifecore Biomedical Inc
10/31/20244:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
10/29/20244:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LFCRLifecore Biomedical Inc
10/23/20244:04PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LFCRLifecore Biomedical Inc
10/23/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LFCRLifecore Biomedical Inc
10/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LFCRLifecore Biomedical Inc
10/10/20244:40PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LFCRLifecore Biomedical Inc
10/10/20244:38PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LFCRLifecore Biomedical Inc
10/10/20244:37PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:LFCRLifecore Biomedical Inc
10/10/20244:36PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LFCRLifecore Biomedical Inc
10/07/20241:03PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LFCRLifecore Biomedical Inc
10/04/20247:41AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LFCRLifecore Biomedical Inc
10/04/20247:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LFCRLifecore Biomedical Inc
10/04/20247:30AMGlobeNewswire Inc.Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate UpdateNASDAQ:LFCRLifecore Biomedical Inc
10/04/20247:20AMGlobeNewswire Inc.Lifecore Biomedical Raises $24.3 Million in Private Placement of Common StockNASDAQ:LFCRLifecore Biomedical Inc
10/03/20244:05PMGlobeNewswire Inc.Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024NASDAQ:LFCRLifecore Biomedical Inc
10/01/20247:00AMGlobeNewswire Inc.Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation TechnologyNASDAQ:LFCRLifecore Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:LFCR